Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-02-06
2007-02-06
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S018700, C530S326000, C530S330000
Reexamination Certificate
active
10481662
ABSTRACT:
A peptide of the formula (Xaa)n1-Xaa1-His-Thr-Asp-(Xaa)n2, wherein Xaa is any amino acid; Xaa1is a hydrophobic amino acid, preferably Gly or Val; n1 is 0–10; and n2 is 0–10; and use thereof in regulating in vivo blood glucose levels in a human or other mammal, particularly in the treatment of Type 2 diabetes in a human. Preferably, the peptide is a tetrapeptide selected from Gly-His-Thr-Asp and Val-His-Thr-Asp. These hypoglycaemic peptides are isolated from human urine and they also have been chemically synthesized.
REFERENCES:
patent: 4596790 (1986-06-01), Trygstad et al.
patent: 5561116 (1996-10-01), Nakamura et al.
patent: 6048840 (2000-04-01), Hearn et al.
patent: 6803189 (2004-10-01), Keesee et al.
patent: 2004/0198650 (2004-10-01), Jensen
patent: WO 98/09170 (1998-03-01), None
Ng et al. Insulin Potentiating Action of a Peptide Fraction from Human Urine. Diabetes. Dec. 1974, vol. 23, No. 12, pp. 950-956.
Boge, A., et al., “A Nonradioactive Assay for the Insulin Receptor Tyrosine Kinase: Use in Monitoring Receptor Kinase Activity After Activation of Overexpressed Protein Kinase C Alpha and High Glucose Treatment,”Anal. Biochem. 231(2):323-32, Nov. 1, 1995.
Ng Frank Man-Woon
Zimmet Paul Zev
International Diabetes Institute
Monash University
Russel Jeffrey Edwin
Seed IP Law Group PLLC
LandOfFree
Hypoglycaemic peptides and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycaemic peptides and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycaemic peptides and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3831199